This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More
Microfluidics Market By Material Type (Glass, Silicon, Metal), Application (Point of care testing, Clinical Diagnostics, Drug Delivery), Industry (Pharmaceuticals, In-vitro Diagnostics, Environmental Research) & Region - Forecast to 2016 - 2026

Microfluidics Market By Material Type (Glass, Silicon, Metal), Application (Point of care testing, Clinical Diagnostics, Drug Delivery), Industry (Pharmaceuticals, In-vitro Diagnostics, Environmental Research) & Region - Forecast to 2016 - 2026

Microfluidics Market - Analysis, Outlook, Growth, Trends, Forecasts

Microfluidics Market Overview

[183 Pages Report] The microfluidics market is valued at US$ 5.6 Billion in 2021. The market is likely to grow at a CAGR of 14.4% through 2026, reaching US$ 11 Billion.

Attribute

Details

Estimated Market Size of Microfluidics Market in 2021

US$ 5.6 Bn

Projected Market Size of Microfluidics Market in 2026

US$ 11 Bn

CAGR during 2021-2026

14.4%

North America, Western Europe and APEJ are the lucrative regions of the market, collectively accounting for 61% of the market revenue.

Through 2026, the ceramics segment is predicted to maintain its dominance, with a 42% market share, followed by glass, polymer, and silicon. While the polymer industry, led by PVC, is expected to rise at a CAGR of 15%.

Through 2026, the fastest-growing segment in-vitro diagnostics is expected to hold a market share of 35%.

An increasing use of point of care testing devices is likely to drive the growth of the point of care testing segment

Increasing demand for microfluidics technology based point of care devices and kits in in-vitro diagnostics is expected to propel the growth of the point of care segment over the forecast period. Point of care testing devices have significant applications in the field of genomics and proteomics. For instance, these devices help identify the DNAs of microbes that are responsible for causing various diseases and are also used in protein analysis.

A prominent feature of these devices is that these can be used at bedside, hospitals, in the delivery room, in intensive care units, in doctor's offices, in emergency rooms, in pharmacies, at home for self-testing, and even in space owing to their size, disposability and integration of complex functions. An increasing use of point of care testing devices across various end-use industries is likely to drive the growth of the point of care testing segment during 2016 – 2026.

Due to increase in price pressures in various countries, companies operating in the global microfluidics market have shifted their focus to developing low-cost diagnostic devices that can provide accurate results in less time. Hence, point of care microfluidics devices have gained traction over the years owing to benefits such as low cost of development and capability to generate accurate and reliable results rapidly.

Furthermore, these devices occupy less space and need fewer volumes of samples for analysis than conventional diagnostic devices, thereby decreasing operational costs. The funding that drives the development of point of care technologies comes from multiple sources including the NIH and the U.S. Department of Defense (DOD), as well as private foundations such as the Bill and Melinda Gates Foundation and other pharmaceutical industry foundations / associations.

Point of care segment is expected to register high revenue growth in Western Europe

In North America, by application type, the point of care testing segment is expected to register high revenue growth and exhibit a market attractiveness index of 1.19 over the forecast period, while in Latin America, the point of care testing segment is projected to register high revenue growth and exhibit a market attractiveness index of 1.48 over the forecast period.

In Western Europe, this segment is anticipated to register high revenue growth and exhibit a market attractiveness index of 1.6 between 2016 and 2026. In Eastern Europe, the point of care testing segment is predicted to register increased revenue growth and record a market attractiveness index of 1.46 over the coming decade; while in APEJ, Future Market Insights analysts estimate the point of care testing segment to register high revenue growth, exhibiting a market attractiveness index of 1.35 over the projected period.

Sign Up with MarketNgage

World's Most Profilic Intelligence Engine

Get Access To The World's Largest Market Research Database.

Sign Up Now

The global microfluidics market is divided into the following segments:

Material Type

  • Polymer
    • Polyvinyl chloride (PVC)
    • Non-polyvinyl chloride
  • Glass
  • Silicon
  • Metal
  • Ceramics

Application Type

  • Point of care testing
  • Clinical Diagnostics
  • Drug Delivery
  • Analytical Testing
    • Genomics
    • Proteomics
    • Cell Based Analysis
    • others

Industry

  • Pharmaceuticals
  • In-vitro Diagnostics
  • Environmental Research
  • Life Science Research
  • Clinical Diagnostics

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

Key Questions Answered in the Report

What is the outlook of the microfluidics market?

The microfluidics market is valued at US$ 5.6 Billion in 2021. The market is likely to grow at a CAGR of 14.4% through 2026, reaching US$ 11 Billion.
Some of the most prominent players include Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc.

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

China First Aid Market

Published : 2015-07-14

Healthcare

Surgical Generators Market

Published : 2021-12-17

Healthcare

Prosthetic Heart Valve Market

Published : 2016-10-20

Healthcare

Continuous Glucose Monitoring Systems Market

Published : 2015-07-28